Service overview

The adult neuro-oncology service operates across 2 sites: The Christie NHS Foundation Trust and Salford Royal Foundation Trust (SRFT).

It complies with the NICE Improving Outcome Guidance for Brain and Spinal Tumours. Children and teenage and young adult (TYA) patients (less than 25 years old) are managed via the paediatric and TYA services; some staff work in both services.

All brain and spinal tumour surgery (neurosurgery), new patient clinics and stereotactic radiosurgery (a special type of highly-targeted radiotherapy) take place at Salford Royal FT.

Subsequent treatment including chemotherapy (drug treatment), radiotherapy (X-ray treatment) and follow-up occurs at The Christie. You can read more about the treatment we offer here. 

Supportive care (including symptom control, psychological support and rehabilitation) and survivorship (coping with the effects of diagnosis or treatment) are addressed throughout the patient journey via links from both Trusts with community teams. More information is available here.

Clinical research in the form of drug and treatment trials take place predominantly at The Christie; other research e.g. drug penetration and imaging studies are carried out at SRFT or the Wolfson Molecular Imaging Centre (WMIC), next door to The Christie.

Although based across 2 sites, the team works cohesively as one. The Christie staff work across both sites to undertake MDTs (multidisciplinary team meetings) and clinics to facilitate patient-centred joined-up care.

We hope that the information contained in the following pages provides you with an insight into our service, our team and the treatment, research and support that we offer. 

;